Literature DB >> 5297802

Phage resistance in Vibrio cholerae.

S Rizvi, A S Benenson.   

Abstract

Mukerjee cholera phages are being extensively used in the classification of vibrios. However, the studies reported here show that phage-resistant mutants that are exactly like the parent strains in all characteristics except phage reactions can easily be obtained. For this reason phage reactions should be considered only as a marker and not as the final arbiter in vibrio classification, e.g., in attempting to identify the El Tor vibrio. Confirmatory evidence should always be sought.It is also shown that routine phage work can be simplified by preparing phage-specific hosts and using them for the preparation of phage stocks without any fear of cross-contamination. The properties of phages prepared on the specific hosts are similar to those of phages prepared on the universal host.

Entities:  

Mesh:

Year:  1966        PMID: 5297802      PMCID: PMC2476232     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  4 in total

1.  ISOLATION OF HEMAGGLUTINATIVE NON-EL TOR CHOLERA VIBRIOS.

Authors:  S RIZVI; M I HUQ; A S BENENSON
Journal:  J Bacteriol       Date:  1965-03       Impact factor: 3.490

2.  Treatment and prophylaxis of cholera with bacteriophage.

Authors:  R M SAYAMOV
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

3.  Bacteriophage-Resistant Mutants in Escherichia Coli.

Authors:  M Demerec; U Fano
Journal:  Genetics       Date:  1945-03       Impact factor: 4.562

4.  CLASSIFICATION OF VIBRIO CHOLERAE (VIBRIO COMMA), INCLUDING EL TOR VIBRIOS, BY INFRASUBSPECIFIC CHARACTERISTICS.

Authors:  J C FEELEY
Journal:  J Bacteriol       Date:  1965-03       Impact factor: 3.490

  4 in total
  1 in total

1.  Polyphasic taxonomy of the genus vibrio: numerical taxonomy of Vibrio cholerae, Vibrio parahaemolyticus, and related Vibrio species.

Authors:  R R Colwell
Journal:  J Bacteriol       Date:  1970-10       Impact factor: 3.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.